# VSBC (Vitaspring Biomedical Co., Ltd.) - SEC EDGAR Financial Statements

> Vitaspring Biomedical Co., Ltd. reported $0 in revenue and a net loss of $456K for the trailing twelve months ended July 31, 2026.

- Canonical: https://convexityos.com/fundamentals/VSBC
- Markdown: https://convexityos.com/fundamentals/VSBC.md
- SEC CIK: 0001697884
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001697884&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Jul 31, 2026 |
| Operating Income | TTM | -$455K | Operating profit |
| Net Income | TTM | -$456K | GAAP bottom line |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Jul 31, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $5.61M | $248K | $15K | $17K | $16K | $0 |
| Cost of Revenue | $0 | $0 | $0 | $3.33M | $3.55M | $136K | $13K | $3.5K | $4.9K | $0 |
| **Gross Profit** | $0 | $0 | $0 | -$3.33M | $2.07M | $112K | $1.7K | $14K | $11K | $0 |
| Selling, General & Admin | $385K | $680K | $1.12M | $845K | $941K | $538K | $21K | $36K | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -$36K | -$18K | -$45 |
| **Operating Income** | -$385K | -$680K | -$1.12M | -$4.18M | $1.13M | $425K | $6.9K | -$22K | -$6.4K | $45 |
| **EBITDA** | -$375K | -$670K | -$1.10M | -$4.16M | $1.14M | $425K | $7.4K | -$22K | -$6.0K | $45 |
| Income Before Tax | -$385K | -$680K | -$1.12M | -$4.17M | $1.13M | -$425K | $6.9K | -$22K | -- | -- |
| Income Tax Expense | $30K | $95K | $0 | -$5.4K | $217K | $0 | $0 | $0 | -- | -- |
| **Net Income** | -$415K | -$775K | -$1.12M | -$4.16M | $910K | $425K | $6.9K | -$22K | -$6.4K | -$45 |
| Basic EPS | -- | -- | -- | -- | -- | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | $0.00 | $0.00 | -$0.01 | -$0.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | 206.0M | 91.1M | -- | -- | -- | -- |
| Diluted Shares Outstanding | 207.0M | 207.0M | 207.0M | 206.5M | 206.0M | 91.1M | 10.9M | 9.8M | 2.3M | 49.3K |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Selling, General & Admin | $5.8K | $76K | $81K | $136K | $6.1K | $69K | $126K | $118K |
| Total Operating Expenses | $162K | -- | -- | -- | $99K | -- | -- | -- |
| **Operating Income** | -$162K | -$76K | -$81K | -$136K | -$99K | -$69K | -$126K | -$118K |
| **EBITDA** | -- | -$73K | -$79K | -$133K | -$97K | -$67K | -$124K | -$115K |
| Income Before Tax | -$156K | -$76K | -$81K | -$136K | -$99K | -$69K | -$126K | -$118K |
| Income Tax Expense | $0 | $0 | $0 | $6.8K | $12K | $11K | $17K | $78K |
| **Net Income** | -$156K | -$76K | -$81K | -$143K | -$111K | -$81K | -$143K | -$196K |
| **Diluted EPS** | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 |
| Diluted Shares Outstanding | 207.0M | 207.0M | -- | 207.0M | 207.0M | 207.0M | -- | 207.0M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $0 | $0 | -- | $107K | $45K | $0 | $105 | $5.2K | $555 |
| **Cash & Short-Term Investments** | -- | $0 | $0 | -- | $107K | $0 | $0 | $105 | $5.2K | $555 |
| Accounts Receivable, Net | -- | $0 | $0 | $380K | $2.95M | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | $0 | $0 | $144K | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | $8.5K | -- | -- |
| **Total Current Assets** | $11K | $272 | $24K | $437K | $3.06M | $189K | $189K | $10K | $11K | $4.6K |
| Property, Plant & Equipment, Net | $4.1K | $14K | $24K | $50K | $65K | -- | -- | $1.4K | $1.9K | $0 |
| **Total Non-Current Assets** | $4.1K | $14K | $114K | $329K | $542K | $0 | $0 | $11K | $13K | $4.6K |
| **Total Assets** | $15K | $14K | $137K | $766K | $3.60M | $189K | $189K | $0 | $1.9K | $0 |
| Accounts Payable | $2.41M | $2.41M | $2.41M | $2.41M | $1.25M | -- | -- | $0 | $1.4K | $0 |
| Other Current Liabilities | $652K | $495K | $339K | $55K | $0 | $93K | $93K | -- | -- | -- |
| **Total Current Liabilities** | $4.45M | $4.03M | $3.49M | $3.07M | $1.74M | $93K | $93K | $18K | $16K | $1.6K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $93K | $289K | $0 | $0 | $18K | $16K | $1.6K |
| **Total Liabilities** | $4.45M | $4.03M | $3.49M | $3.16M | $2.03M | $93K | $96K | $11K | $13K | $4.6K |
| **Total Debt (incl. Leases)** | -- | -- | $93K | $93K | $479K | -- | -- | -- | -- | -- |
| Common Stock | $21K | $21K | $21K | $21K | $21K | $19K | $10.90M | $0 | $0 | -- |
| Retained Earnings | -$5.70M | -$5.28M | -$4.51M | -$3.39M | $776K | $447K | -$447K | -$29K | -- | -- |
| **Total Stockholders' Equity** | -$4.43M | -$4.02M | -$3.35M | -$2.40M | $1.58M | $96K | $0 | -$6.9K | -$3.4K | $3.0K |
| Total Equity | -$4.43M | -$4.02M | -$3.35M | -$2.40M | $1.58M | $96K | $0 | -$6.9K | -$3.4K | $3.0K |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $0 | $0 | $0 | $0 | $2.1K |
| **Cash & Short-Term Investments** | -- | -- | -- | $0 | $0 | $0 | $0 | $2.1K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Total Current Assets** | $15K | $9.8K | $11K | $9.8K | $7.9K | $295 | $272 | $42K |
| Property, Plant & Equipment, Net | $0 | $1.7K | $4.1K | $6.6K | $9.1K | $12K | $14K | $17K |
| **Total Non-Current Assets** | $0 | $1.7K | $4.1K | $6.6K | $9.1K | $12K | $14K | $17K |
| **Total Assets** | $15K | $11K | $15K | $16K | $17K | $12K | $14K | $58K |
| Accounts Payable | $0 | -- | $2.41M | $2.41M | $2.41M | $2.41M | $2.41M | $2.41M |
| Other Current Liabilities | -- | $712K | $652K | -- | -- | $530K | $495K | $446K |
| **Total Current Liabilities** | $2.27M | $4.52M | $4.45M | $4.37M | $4.22M | $4.11M | $4.03M | $3.93M |
| **Total Non-Current Liabilities** | $2.41M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $4.68M | $4.52M | $4.45M | $4.37M | $4.22M | $4.11M | $4.03M | $3.93M |
| Common Stock | $21K | $21K | $21K | $21K | $21K | $21K | $21K | $21K |
| Retained Earnings | -$5.93M | -$5.77M | -$5.70M | -$5.62M | -$5.47M | -$5.36M | -$5.28M | -$5.14M |
| **Total Stockholders' Equity** | -$4.66M | -$4.51M | -$4.43M | -$4.35M | -$4.21M | -$4.10M | -$4.02M | -$3.87M |
| Total Equity | -$4.66M | -$4.51M | -$4.43M | -$4.35M | -$4.21M | -$4.10M | -$4.02M | -$3.87M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$415K | -$775K | -$1.12M | -$4.16M | $910K | $425K | $6.9K | -$22K | -$6.4K | -$45 |
| Depreciation & Amortization | $10.0K | $10.0K | $15K | $15K | $8.4K | $0 | $450 | $450 | $375 | $0 |
| Stock-Based Compensation | $0 | $110K | $165K | $190K | $167K | $434K | -- | -- | -- | -- |
| Change in Receivables | -- | $0 | $380K | $2.54M | -$2.95M | -- | -- | -- | -- | -- |
| Change in Inventory | -- | -- | -- | $0 | $144K | -$144K | -- | -- | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | -$1.4K | $1.4K | $0 |
| **Operating Cash Flow** | -$2.7K | -$15K | -$35K | -$78K | -$270K | -$42K | $105 | -$34K | $401 | -$4.0K |
| Capital Expenditure | -- | -- | -- | $0 | -$73K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -- | -- | -- | -$78K | -$343K | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -- | -- | -- | $0 | -$73K | -- | -- | $0 | -$2.2K | $0 |
| Common Stock Issued | -- | -- | -- | $0 | $50K | $8.7K | $0 | $19K | $0 | $3.0K |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -- | -$100 | -- |
| **Financing Cash Flow** | $4.5K | $15K | $5.3K | $0 | $50K | $88K | $0 | $29K | $6.5K | $4.6K |
| **Net Change in Cash** | $1.8K | $259 | -$30K | -$78K | -$293K | $45K | -$105 | -$5.1K | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$156K | -$76K | -$81K | -$143K | -$111K | -$81K | -$143K | -$196K |
| Depreciation & Amortization | -- | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K |
| Stock-Based Compensation | -- | -- | $0 | $0 | $0 | $0 | $0 | $27K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Operating Cash Flow** | $5.2K | $6.1K | $124 | -$839 | -$1.2K | -$787 | -$1.8K | -$6.4K |
| **Financing Cash Flow** | $0 | $0 | $0 | $2.0K | $2.0K | $515 | $0 | $3.0K |
| **Net Change in Cash** | $5.2K | $6.1K | $124 | $1.2K | $799 | -$272 | -$1.8K | -$3.5K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | 36.8% | 45.2% | 11.2% | 79.8% | 69.9% | -- |
| **Operating Margin** | -- | -- | -- | -- | 20.1% | 171.4% | 45.7% | -130.4% | -39.3% | -- |
| **Net Profit Margin** | -- | -- | -- | -- | 16.2% | 171.4% | 45.7% | -130.4% | -39.3% | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | 57.7% | 441.4% | -- | -- | -- | -1.5% |
| Return on Assets (ROA) | -2830.3% | -5389.6% | -814.4% | -543.7% | 25.2% | 224.6% | 3.7% | -- | -340.1% | -- |
| Current Ratio | 0.00x | 0.00x | 0.01x | 0.14x | 1.76x | 2.04x | 2.04x | 0.55x | 0.68x | 2.85x |
| Quick Ratio | -- | 0.00x | 0.00x | 0.14x | 1.76x | 0.49x | 0.00x | 0.01x | 0.32x | 0.35x |
| Debt to Equity | -- | -- | -- | -- | 0.30x | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -100.0% | +2161.6% | +1539.4% | -11.9% | +5.9% | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -261.2% | +1743.1% | +6519.5% | -87.6% | +21.0% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -470.8% | +164.9% | +6048.0% | -- | -- | -14264.4% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -557.8% | +113.8% | +6048.0% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -40223.8% | -- | -8640.6% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -3074.1% | -3592.3% | -2830.3% | -2897.3% | -3118.8% | -5361.2% | -5389.6% | -1468.2% |
| Current Ratio | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x |
| Quick Ratio | -- | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
